Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,735
archived clinical trials in
Psoriasis

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Therapeutics Clinical Research
mi
from
San Diego, CA
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Therapeutics Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Horizons Clinical Research Center, LLC
mi
from
Denver, CO
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Horizons Clinical Research Center, LLC
mi
from
Denver, CO
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Miami Research Associates
mi
from
Miami, FL
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Miami Research Associates
mi
from
Miami, FL
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Advanced Dermatology and Cosmetic Surgery
mi
from
Ormond Beach, FL
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Advanced Dermatology and Cosmetic Surgery
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Stedman Clinical Trials
mi
from
Tampa, FL
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Stedman Clinical Trials
mi
from
Tampa, FL
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Northwest Clinical Trials
mi
from
Boise, ID
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Northwest Clinical Trials
mi
from
Boise, ID
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Deaconess Clinic Downtown-Research Institute
mi
from
Evansville, IN
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Deaconess Clinic Downtown-Research Institute
mi
from
Evansville, IN
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
DermResearch, PLLC
mi
from
Louisville, KY
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
DermResearch, PLLC
mi
from
Louisville, KY
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Michigan Center for Skin Care Research
mi
from
Clinton Township, MI
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Michigan Center for Skin Care Research
mi
from
Clinton Township, MI
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Academic Dermatology
mi
from
Albuquerque, NM
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Academic Dermatology
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Derm Research Center of New York, Inc.
mi
from
Stony Brook, NY
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Derm Research Center of New York, Inc.
mi
from
Stony Brook, NY
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Wake Research Associates, LLC
mi
from
Raleigh, NC
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Wake Forest University Health Sciences - Dermatology Studies
mi
from
Winston-Salem, NC
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Wake Forest University Health Sciences - Dermatology Studies
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Toledo Center for Clinical Research
mi
from
Sylvania, OH
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Toledo Center for Clinical Research
mi
from
Sylvania, OH
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Oklahoma University Health Sciences Center, Dermatology Dept
mi
from
Oklahoma City, OK
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Oklahoma University Health Sciences Center, Dermatology Dept
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Paddington Testing Co., Inc.
mi
from
Philadelphia, PA
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Paddington Testing Co., Inc.
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Clinical Partners, LLC
mi
from
Johnston, RI
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Clinical Partners, LLC
mi
from
Johnston, RI
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Radiant Research
mi
from
Greer, SC
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Radiant Research
mi
from
Greer, SC
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
J&S Studies
mi
from
College Station, TX
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
J&S Studies
mi
from
College Station, TX
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Baylor Research Institute of Dermatology Department
mi
from
Dallas, TX
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Baylor Research Institute of Dermatology Department
mi
from
Dallas, TX
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Dermatology Associates of San Antonio
mi
from
San Antonio, TX
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Dermatology Associates of San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Intermountain Clinical Research
mi
from
Draper, UT
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Intermountain Clinical Research
mi
from
Draper, UT
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Commonwealth Clinical Research Specialists, Inc.
mi
from
Richmond, VA
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Commonwealth Clinical Research Specialists, Inc.
mi
from
Richmond, VA
Click here to add this to my saved trials
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  10/19/2015
Premier Clinical Research
mi
from
Spokane, WA
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 10/19/2015
Premier Clinical Research
mi
from
Spokane, WA
Click here to add this to my saved trials
Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis
A Long-term Assessment of the Safety and Efficacy of AMG 827 Subcutaneous Treatment in Subjects With Psoriasis
Status: Enrolling
Updated:  10/20/2015
Clinical Research Facility
mi
from
Newnan, GA
Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis
A Long-term Assessment of the Safety and Efficacy of AMG 827 Subcutaneous Treatment in Subjects With Psoriasis
Status: Enrolling
Updated: 10/20/2015
Clinical Research Facility
mi
from
Newnan, GA
Click here to add this to my saved trials
Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis
A Long-term Assessment of the Safety and Efficacy of AMG 827 Subcutaneous Treatment in Subjects With Psoriasis
Status: Enrolling
Updated:  10/20/2015
Clinical Research Facility
mi
from
Skokie, IL
Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis
A Long-term Assessment of the Safety and Efficacy of AMG 827 Subcutaneous Treatment in Subjects With Psoriasis
Status: Enrolling
Updated: 10/20/2015
Clinical Research Facility
mi
from
Skokie, IL
Click here to add this to my saved trials
Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis
A Long-term Assessment of the Safety and Efficacy of AMG 827 Subcutaneous Treatment in Subjects With Psoriasis
Status: Enrolling
Updated:  10/20/2015
Clinical Research Facility
mi
from
St. Louis, MO
Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis
A Long-term Assessment of the Safety and Efficacy of AMG 827 Subcutaneous Treatment in Subjects With Psoriasis
Status: Enrolling
Updated: 10/20/2015
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis
A Long-term Assessment of the Safety and Efficacy of AMG 827 Subcutaneous Treatment in Subjects With Psoriasis
Status: Enrolling
Updated:  10/20/2015
Clinical Research Facility
mi
from
Albuquerque, NM
Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis
A Long-term Assessment of the Safety and Efficacy of AMG 827 Subcutaneous Treatment in Subjects With Psoriasis
Status: Enrolling
Updated: 10/20/2015
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis
A Long-term Assessment of the Safety and Efficacy of AMG 827 Subcutaneous Treatment in Subjects With Psoriasis
Status: Enrolling
Updated:  10/20/2015
Clinical Research Facility
mi
from
Dallas, TX
Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis
A Long-term Assessment of the Safety and Efficacy of AMG 827 Subcutaneous Treatment in Subjects With Psoriasis
Status: Enrolling
Updated: 10/20/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis
A Long-term Assessment of the Safety and Efficacy of AMG 827 Subcutaneous Treatment in Subjects With Psoriasis
Status: Enrolling
Updated:  10/20/2015
Clinical Research Facility
mi
from
Webster, TX
Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis
A Long-term Assessment of the Safety and Efficacy of AMG 827 Subcutaneous Treatment in Subjects With Psoriasis
Status: Enrolling
Updated: 10/20/2015
Clinical Research Facility
mi
from
Webster, TX
Click here to add this to my saved trials
Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis
A Long-term Assessment of the Safety and Efficacy of AMG 827 Subcutaneous Treatment in Subjects With Psoriasis
Status: Enrolling
Updated:  10/20/2015
Research Site
mi
from
Kogarah,
Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis
A Long-term Assessment of the Safety and Efficacy of AMG 827 Subcutaneous Treatment in Subjects With Psoriasis
Status: Enrolling
Updated: 10/20/2015
Research Site
mi
from
Kogarah,
Click here to add this to my saved trials
Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Rising i.v. (Stage 1) and s.c. (Stage 2) Doses of BI 655066 in Male and Female Patients With Moderate to Severe Psoriasis (Randomised, Double-blind, Placebo-controlled Within Dose Groups)
Status: Enrolling
Updated:  10/26/2015
1200.125.10025 Boehringer Ingelheim Investigational Site
mi
from
Burbank, CA
Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Rising i.v. (Stage 1) and s.c. (Stage 2) Doses of BI 655066 in Male and Female Patients With Moderate to Severe Psoriasis (Randomised, Double-blind, Placebo-controlled Within Dose Groups)
Status: Enrolling
Updated: 10/26/2015
1200.125.10025 Boehringer Ingelheim Investigational Site
mi
from
Burbank, CA
Click here to add this to my saved trials
Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Rising i.v. (Stage 1) and s.c. (Stage 2) Doses of BI 655066 in Male and Female Patients With Moderate to Severe Psoriasis (Randomised, Double-blind, Placebo-controlled Within Dose Groups)
Status: Enrolling
Updated:  10/26/2015
Boehringer Ingelheim Investigational Site
mi
from
Miami, FL
Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Rising i.v. (Stage 1) and s.c. (Stage 2) Doses of BI 655066 in Male and Female Patients With Moderate to Severe Psoriasis (Randomised, Double-blind, Placebo-controlled Within Dose Groups)
Status: Enrolling
Updated: 10/26/2015
Boehringer Ingelheim Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Rising i.v. (Stage 1) and s.c. (Stage 2) Doses of BI 655066 in Male and Female Patients With Moderate to Severe Psoriasis (Randomised, Double-blind, Placebo-controlled Within Dose Groups)
Status: Enrolling
Updated:  10/26/2015
1264.3.01019 Boehringer Ingelheim Investigational Site
mi
from
Port Orange, FL
Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Rising i.v. (Stage 1) and s.c. (Stage 2) Doses of BI 655066 in Male and Female Patients With Moderate to Severe Psoriasis (Randomised, Double-blind, Placebo-controlled Within Dose Groups)
Status: Enrolling
Updated: 10/26/2015
1264.3.01019 Boehringer Ingelheim Investigational Site
mi
from
Port Orange, FL
Click here to add this to my saved trials
Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Rising i.v. (Stage 1) and s.c. (Stage 2) Doses of BI 655066 in Male and Female Patients With Moderate to Severe Psoriasis (Randomised, Double-blind, Placebo-controlled Within Dose Groups)
Status: Enrolling
Updated:  10/26/2015
1268.17.01036 Boehringer Ingelheim Investigational Site
mi
from
Normal, IL
Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Rising i.v. (Stage 1) and s.c. (Stage 2) Doses of BI 655066 in Male and Female Patients With Moderate to Severe Psoriasis (Randomised, Double-blind, Placebo-controlled Within Dose Groups)
Status: Enrolling
Updated: 10/26/2015
1268.17.01036 Boehringer Ingelheim Investigational Site
mi
from
Normal, IL
Click here to add this to my saved trials
Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Rising i.v. (Stage 1) and s.c. (Stage 2) Doses of BI 655066 in Male and Female Patients With Moderate to Severe Psoriasis (Randomised, Double-blind, Placebo-controlled Within Dose Groups)
Status: Enrolling
Updated:  10/26/2015
205.452.01153 Boehringer Ingelheim Investigational Site
mi
from
Evansville, IN
Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Rising i.v. (Stage 1) and s.c. (Stage 2) Doses of BI 655066 in Male and Female Patients With Moderate to Severe Psoriasis (Randomised, Double-blind, Placebo-controlled Within Dose Groups)
Status: Enrolling
Updated: 10/26/2015
205.452.01153 Boehringer Ingelheim Investigational Site
mi
from
Evansville, IN
Click here to add this to my saved trials
Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Rising i.v. (Stage 1) and s.c. (Stage 2) Doses of BI 655066 in Male and Female Patients With Moderate to Severe Psoriasis (Randomised, Double-blind, Placebo-controlled Within Dose Groups)
Status: Enrolling
Updated:  10/26/2015
1222.29.11004 Boehringer Ingelheim Investigational Site
mi
from
North Dartmouth, MA
Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Rising i.v. (Stage 1) and s.c. (Stage 2) Doses of BI 655066 in Male and Female Patients With Moderate to Severe Psoriasis (Randomised, Double-blind, Placebo-controlled Within Dose Groups)
Status: Enrolling
Updated: 10/26/2015
1222.29.11004 Boehringer Ingelheim Investigational Site
mi
from
North Dartmouth, MA
Click here to add this to my saved trials
Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Rising i.v. (Stage 1) and s.c. (Stage 2) Doses of BI 655066 in Male and Female Patients With Moderate to Severe Psoriasis (Randomised, Double-blind, Placebo-controlled Within Dose Groups)
Status: Enrolling
Updated:  10/26/2015
Boehringer Ingelheim Investigational Site
mi
from
Pittsburgh, PA
Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Rising i.v. (Stage 1) and s.c. (Stage 2) Doses of BI 655066 in Male and Female Patients With Moderate to Severe Psoriasis (Randomised, Double-blind, Placebo-controlled Within Dose Groups)
Status: Enrolling
Updated: 10/26/2015
Boehringer Ingelheim Investigational Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Rising i.v. (Stage 1) and s.c. (Stage 2) Doses of BI 655066 in Male and Female Patients With Moderate to Severe Psoriasis (Randomised, Double-blind, Placebo-controlled Within Dose Groups)
Status: Enrolling
Updated:  10/26/2015
1311.1.4901 Boehringer Ingelheim Investigational Site
mi
from
Berlin,
Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Rising i.v. (Stage 1) and s.c. (Stage 2) Doses of BI 655066 in Male and Female Patients With Moderate to Severe Psoriasis (Randomised, Double-blind, Placebo-controlled Within Dose Groups)
Status: Enrolling
Updated: 10/26/2015
1311.1.4901 Boehringer Ingelheim Investigational Site
mi
from
Berlin,
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Burke Pharmaceutical Research
mi
from
Hot Springs, AR
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Burke Pharmaceutical Research
mi
from
Hot Springs, AR
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
UC Irvine Dermatology Research
mi
from
Irvine, CA
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
UC Irvine Dermatology Research
mi
from
Irvine, CA
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Dermatology Research Associates
mi
from
Los Angeles, CA
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Dermatology Research Associates
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Park Avenue Dermatology
mi
from
Orange Park, FL
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Park Avenue Dermatology
mi
from
Orange Park, FL
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Olympian Clinical Research
mi
from
Tampa, FL
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Olympian Clinical Research
mi
from
Tampa, FL
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Atlanta Dermatology, Vein & Research Ctr
mi
from
Alpharetta, GA
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Atlanta Dermatology, Vein & Research Ctr
mi
from
Alpharetta, GA
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Advanced Medical Research, Inc.
mi
from
Atlanta, GA
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Advanced Medical Research, Inc.
mi
from
Atlanta, GA
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
MedaPhase, Inc.
mi
from
Newnan, GA
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
MedaPhase, Inc.
mi
from
Newnan, GA
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Dundee Dermatology
mi
from
West Dundee, IL
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Dundee Dermatology
mi
from
West Dundee, IL
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Tufts Medical Center
mi
from
Boston, MA
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  10/26/2015
Massachusetts General Hospital - Clinical Unit for Research Trials in Skin (CURTIS)
mi
from
Boston, MA
Tofacitinib Ointment For Chronic Plaque Psoriasis
A Phase 2b, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Efficacy, Safety, Local Tolerability And Pharmacokinetics Of 2 Dose Strengths And 2 Regimens Of Tofacitinib Ointment In Subjects With Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 10/26/2015
Massachusetts General Hospital - Clinical Unit for Research Trials in Skin (CURTIS)
mi
from
Boston, MA
Click here to add this to my saved trials